Abstract
We have earlier reported that γ-hydroxybutyric acid (GHB) disrupts the acquisition of spatial learning and memory in adolescent rats. GHB is known to interact with several neurotransmitter systems that have been implicated in cognitive functioning. The N-methyl-D-aspartate receptor (NR) -type of glutamate receptor is considered to be an important target for spatial learning and memory. Molecular mechanisms governing the neuroadptations following repeated GHB treatment in adolecent rats remain unknown. We examined the role of NMDA receptor in adolescent GHB-induced cognitive deficit. Adolescent rats were administered with GHB on 6 consecutive days, and surface-expressed NMDA receptor subunits levels were measured. GHB significantly decreased NR1 levels in the frontal cortex. Adolescent GHB also significantly reduced cortical NR2A subunit levels. Our findings support the hypothesis that adolescent GHB-induced cogntive deficits are associated with neuroadaptations in glutamatergic transmission, particulaly NR functioning in the frontal cortex.
Keywords: Addiction, juvenile, cognitive function, glutamatergic, radioligand binding, western blot, NR subunit, GHB, presynaptic terminal, NR subunit, GHB, NMDA receptor, NMDA receptor antagonists
Current Neuropharmacology
Title: GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor
Volume: 9 Issue: 1
Author(s): R. Sircar, L-C. Wu, K. Reddy, D. Sircar and A. K. Basak
Affiliation:
Keywords: Addiction, juvenile, cognitive function, glutamatergic, radioligand binding, western blot, NR subunit, GHB, presynaptic terminal, NR subunit, GHB, NMDA receptor, NMDA receptor antagonists
Abstract: We have earlier reported that γ-hydroxybutyric acid (GHB) disrupts the acquisition of spatial learning and memory in adolescent rats. GHB is known to interact with several neurotransmitter systems that have been implicated in cognitive functioning. The N-methyl-D-aspartate receptor (NR) -type of glutamate receptor is considered to be an important target for spatial learning and memory. Molecular mechanisms governing the neuroadptations following repeated GHB treatment in adolecent rats remain unknown. We examined the role of NMDA receptor in adolescent GHB-induced cognitive deficit. Adolescent rats were administered with GHB on 6 consecutive days, and surface-expressed NMDA receptor subunits levels were measured. GHB significantly decreased NR1 levels in the frontal cortex. Adolescent GHB also significantly reduced cortical NR2A subunit levels. Our findings support the hypothesis that adolescent GHB-induced cogntive deficits are associated with neuroadaptations in glutamatergic transmission, particulaly NR functioning in the frontal cortex.
Export Options
About this article
Cite this article as:
Sircar R., Wu L-C., Reddy K., Sircar D. and K. Basak A., GHB – Induced Cognitive Deficits During Adolescence and the Role of NMDA Receptor, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017038
DOI https://dx.doi.org/10.2174/157015911795017038 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Neuroinflammation and Ageing: Current Theories and an Overview of the Data
Reviews on Recent Clinical Trials Self-Monitoring in Schizophrenia
Current Psychiatry Reviews Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Justification for Domestic Violence and Women’s Autonomy in Zambia
Applied Clinical Research, Clinical Trials and Regulatory Affairs The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals Gene Patents Related to Common Diseases of the Eye
Recent Patents on DNA & Gene Sequences Obesity and Herbal Drug Research: Exploring the Safer Alternative and Lead Molecule
Current Traditional Medicine A Review of the ADAMTS Family, Pharmaceutical Targets of the Future
Current Pharmaceutical Design Recent Developments on Future Antidepressant-related Serotonin Receptors
Current Pharmaceutical Design Contributions of Functional Neuroimaging to Clinical and Cognitive Neuropsychology: A Selective Review
Current Medical Imaging Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Chinese Character Voice Processing of the Bilateral Inferior Parietal Lobule of Literate Compared with Illiterate Subjects: An fMRI Study
Neuroscience and Biomedical Engineering (Discontinued) Assessment of Mobility Status and Risk of Mobility Disability in Older Persons
Current Pharmaceutical Design Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Synthesis, Biological Evaluation and in silico Studies of Novel 5α-aza-Bhomo-3,5-secosteroids as Potential 5-reductase Inhibitors
Letters in Drug Design & Discovery Folate Status and Depressive Symptoms in Reproductive-Age Women
Current Nutrition & Food Science Special Issue on Programmed Cell Death in Stroke
Current Neuropharmacology Why are Antidepressant Drugs Effective Smoking Cessation Aids?
Current Neuropharmacology State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies
Current Medicinal Chemistry